IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods. 42 RA patients who received 6 intravenous TCZ infusions at dose 8 mg/kg given once...

詳細記述

書誌詳細

出版年:	Научно-практическая ревматология
主要な著者:	Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov
フォーマット:	論文
言語:	ロシア語
出版事項:	IMA PRESS LLC 2012-10-01
主題:	sdai cdai rheumatoid arthritis tocilizumab radiographic progression
オンライン･アクセス:	https://rsp.mediar-press.net/rsp/article/view/1090